Guanfacine in Comorbid ADHD & Tourette’s Syndrome

Abstract

An open-label study of guanfacine (1.5 mg/d), an a-adrenergic agonist, in 10 children with TS + ADHD, aged 8 to 16 years, was reported from the Yale University School of Medicine, New Haven, CT, and Johns Hopkins Medical Institutions, Baltimore, MD.

Keywords

• open-label study
• commission errors
• phonic tics